Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 13.414% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] Cc1nc(Cl)c2c(n1)N(CC(N)=O)C(=O)CO2
[b] CCn1c(-c2ccc(-c3ccccc3)cc2)c[nH]c1=S
Answer: a. Cc1nc(Cl)c2c(n1)N(CC(N)=O)C(=O)CO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(Cl)c2c(n1)N(CC(N)=O)C(=O)CO2
Cc1nc(Cl)c2c(n1)N(CC(N)=O)C(=O)CO2
2-(4-chloro-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl)acetamide